Remmie Health, an ear-nose-throat telemedicine company, announced that it has been selected as one of the presenting companies at the 22nd annual SoCalBio conference, which is taking place virtually this year from October 21 to 23. The three-day-long virtual conference will focus on the latest technology trends and business development/partnership opportunities in fields such as COVID-19 diagnostics and therapeutics, bioelectronic medicine and AI (artificial intelligence). As an AI-enabled otoscope business for tracking ear infection, Remmie Health will be presented by its Chief Technology Officer (CTO), Zhan Wang, on October 23 between 2 PM and 3 PM PST.

Remmie Health was selected from a large pool of applicants by members of SoCalBio’s Innovation Catalyst Program, a unique network of senior bioscience and healthcare professionals who provide presentation and business coaching for SoCalBio Conference presenters.

Pre-registration is required to attend the Conference. More information is available at http://socalbioinvest.com/register.

About SoCalBio
SoCalBio is a nonprofit, member-supported trade association that promotes bioscience research, development, manufacturing, job creation and overall economic growth in the Greater Los Angeles region. The Council’s programs help local firms gain access to capital, potential partners and business support services. SoCalBio also promotes technology transfer and workforce training, while informing policymakers and the public-at-large about the benefits of the L.A. region’s life-science industry. More information about SoCalBio is available at www.socalbio.org.

 

Contact:
Yijin Kim
PR Manager
yijin@remmiehealth.com

Editor: Yijin Kim